Company
Sanofi
Sanofi is an R&D-driven, AI-powered biopharmaceutical company developing medicines and vaccines across five therapeutic areas: immunology, neurology, oncology, rare diseases, and vaccines. The company serves patients globally with a pipeline of 61 compounds in clinical development. Sanofi also operates Opella, a consumer healthcare division, and pursues partnerships and external innovation initiatives.
Sanofi is a publicly traded company operating in the pharmaceutical industry sector, based in France. It trades on the New York Stock Exchange under the ticker SNY.
Leadership
Former
Recent developments
AI summary of recent coverageRecent coverage has focused on leadership changes at Sanofi, with Paul Hudson's departure as CEO and the appointment of Belén Garijo, formerly of Merck KGaA, to lead the company. The transition has prompted discussion of Hudson's legacy at Sanofi, including the success of Dupixent alongside acknowledged research and development setbacks, while commentary has centered on questions about Garijo's growth strategy for the organization moving forward.
Summarized from the headlines in the sidebar; see each source for the full story.